StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CRISPR Therapeutics AG
NasdaqGM:CRSP
Sector
Industries
Location
Market Cap
USD 5.62 B
Share Price
USD 65.13
Avg Daily Volume
2,587,653
Change (1 day)
18.22%
Change (1 year)
15.87%
Change (YTD)
65.47%
CRISPR Therapeutics AG Total Liabilities for the year ending December 31, 2024: USD 309.95 M
CRISPR Therapeutics AG Total Liabilities is USD 309.95 M for the year ending December 31, 2024, a -10.62% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
-
CRISPR Therapeutics AG Total Liabilities for the year ending December 31, 2023 was USD 346.77 M, a -5.66% change year over year.
-
CRISPR Therapeutics AG Total Liabilities for the year ending December 31, 2022 was USD 367.58 M, a 4.30% change year over year.
-
CRISPR Therapeutics AG Total Liabilities for the year ending December 31, 2021 was USD 352.42 M, a 115.24% change year over year.
-
CRISPR Therapeutics AG Total Liabilities for the year ending December 31, 2020 was USD 163.73 M, a 28.59% change year over year.
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Siemens Healthineers AG
USD 53.60
SHL.DE
-0.42
-0.77%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Key Data
| Date | Total Liabilities | Shareholders' Equity | Cash and Short-Term Investments | Receivables |
|---|
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Siemens Healthineers AG
USD 53.60
SHL.DE
-0.42
-0.77%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%